Postcholecystectomy syndrome (PCS)

…, S Mohandas, LM Almond - International journal of …, 2010 - journals.lww.com
The term postcholecystectomy syndrome (PCS) comprises a heterogeneous group of symptoms
and findings in patients who have previously undergone cholecystectomy. Although rare…

Myeloid sarcoma: presentation, diagnosis, and treatment

LM Almond, M Charalampakis, SJ Ford… - … Myeloma and Leukemia, 2017 - Elsevier
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition,
most often associated with acute myeloid leukemia (AML), although in some rare cases …

Advances in the clinical application of Raman spectroscopy for cancer diagnostics

C Kallaway, LM Almond, H Barr, J Wood… - Photodiagnosis and …, 2013 - Elsevier
Light interacts with tissue in a number of ways including, elastic and inelastic scattering,
reflection and absorption, leading to fluorescence and phosphorescence. These interactions …

Endoscopic Raman spectroscopy enables objective diagnosis of dysplasia in Barrett's esophagus

LM Almond, J Hutchings, G Lloyd, H Barr… - Gastrointestinal …, 2014 - Elsevier
Background Early detection and targeted endoscopic resection of Barrett's esophagus–associated
high-grade dysplasia (HGD) can prevent progression to invasive esophageal …

A physiologically based pharmacokinetic modeling approach to predict disease–drug interactions: suppression of CYP3A by IL‐6

KK Machavaram, LM Almond… - Clinical …, 2013 - Wiley Online Library
Elevated cytokine levels are known to downregulate expression and suppress activity of
cytochrome P450 enzymes (CYPs). Cytokine‐modulating therapeutic proteins (TPs) used in the …

Vibrational spectroscopy for cancer diagnostics

…, LM Fullwood, R Scott, GR Lloyd, LM Almond… - Analytical …, 2014 - pubs.rsc.org
The vibrational spectroscopy techniques of Raman spectroscopy and Fourier-transform
infrared spectroscopy offer a number of potential advantages as tools for clinical diagnosis. The …

Prediction of drug-drug interactions arising from CYP3A induction using a physiologically based dynamic model

LM Almond, S Mukadam, I Gardner, K Okialda… - Drug Metabolism and …, 2016 - ASPET
Using physiologically based pharmacokinetic modeling, we predicted the magnitude of drug-drug
interactions (DDIs) for studies with rifampicin and seven CYP3A4 probe substrates …

Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals

LM Almond, PG Hoggard, D Edirisinghe… - Journal of …, 2005 - academic.oup.com
Objectives: The site of action of efavirenz is inside HIV-infected cells. Measurement of
intracellular (IC) concentrations of efavirenz may therefore provide further understanding of …

Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing

…, T Parker, JF Wambaugh, LM Almond… - Toxicological …, 2014 - academic.oup.com
Momentum is growing worldwide to use in vitro high-throughput screening (HTS) to evaluate
human health effects of chemicals. However, the integration of dosimetry into HTS assays …

Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance

C Ghobadi, TN Johnson, M Aarabi, LM Almond… - Clinical …, 2011 - Springer
Background and Objectives: The maintenance dose of a drug is dependent on drug clearance,
and thus any biochemical and physiological changes in obesity that affect parameters …